IP Library Granted Patent US 9,938,507
Granted Patent B2
US 9,938,507 · App. 14/836,327 · Granted Apr 10, 2018

Methods of propagating rhinovirus C in previously unsusceptible cell lines

Inventors: James E. Gern (Madison, WI); Yury A. Bochkov (Fitchburg, WI); Ann C. Palmenberg (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N7/00G01N33/5014C12N2770/32751G01N2333/095G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,507
App. No.
14/836,327
Granted
Apr 10, 2018
Kind
B2
Abstract

The present invention provides methods of propagating rhinovirus C (RV-C) in a host cell; a host cell comprising an effective amount of a heterologous CDHR3 receptor such that the host cell can support propagation of rhinovirus C; and kits comprising at least one host cell previously unable to support rhinovirus C growth, wherein the host cell comprises a heterologous CDHR3 receptor and a sample of rhinovirus C. Methods of use are also provided.

Claims (11)

1. A method of propagating rhinovirus C or rhinovirus C variant, the method comprising the steps of:

a. obtaining a host cell comprising at least one heterologous CDHR3 receptor;

and

b. infecting the host cell with a sample of rhinovirus C or rhinovirus C variant;

wherein the rhinovirus C propagates.

2. The method of claim 1 wherein the CDHR3 receptor is a CDHR3-C 529 Y variant.

3. The method of claim 1 wherein the host cell is a cell able to support rhinovirus C replication.

4. The method of claim 3 wherein the host cell is selected from the group consisting of NCI-H358, WI-38, WisL, HEK293T, BEAS-2B, A549 and HeLa.

5. The method of claim 1 wherein the CDHR3 receptor sequence is transduced into the host cell by a viral vector.

6. The method of claim 1 wherein the CDHR3 receptor sequence is transfected into the host cell by lipofection.

7. The method of claim 1 , wherein a viral titer of at least >10e8 PFU equivalents per 10e7 cells grown in monolayer is obtained.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 23, 2018
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045430/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2017
From: GERN, JAMES; BOCHKOV, YURY; PALMENBERG, ANN
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 043006/0473 →
Continuity (3)
Provisional Application 62043517 · Aug 29, 2014
Provisional Application 62203603 · Aug 11, 2015
Related Publication 20170082609A1 · Mar 23, 2017